Our Global Support Program
Boehringer Ingelheim Commits USD 500,000 to American Thoracic Society’s COVID-19 Fund
Boehringer Ingelheim’s support will help the American Thoracic Society (ATS) fight COVID-19 and assist the pulmonology community’s most urgent research, educational and scientific needs